Endue
AI NativeBuilding software for modern infusion operators.
Est 2022|Valuation $13M|Raised $4M
Building software for modern infusion operators.
Published Sep 19, 2026
| Starting Price | Not publicly listed (typically varies by modules and deployment/volume) | Not publicly listed (subscription or volume-based pricing model) | Not publicly listed (contact vendor for custom quotes) |
| Positioning / Suitable For | Infusion centers seeking an integrated workflow platform covering intake, scheduling, inventory, and reporting | Operators seeking a widely deployed infusion and home-infusion workflow platform with a larger public footprint | Oncology/infusion practices prioritizing inventory management and dispensing workflows |
| Key Strengths | Vendor positions the product as an end-to-end infusion workflow platform with emphasis on intake/document workflows, scheduling, embedded messaging, and reporting | Larger public footprint and partner ecosystem as presented in partner communications; emphasis on analytics and interoperability | Inventory specialization and vendor-reported operational metrics; focus on dispensing workflow |
| Key Weaknesses | Limited independent review footprint; public documentation indicates SOC 2 Type I (rather than Type II); a publicly reported security incident is a material diligence item | Pricing transparency is limited; may present a larger system than small centers require | Focused on inventory rather than full patient intake/scheduling; may require integration with other systems |
—